Seung Mo Jin

529 total citations
11 papers, 435 citations indexed

About

Seung Mo Jin is a scholar working on Immunology, Oncology and Biomedical Engineering. According to data from OpenAlex, Seung Mo Jin has authored 11 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Oncology and 5 papers in Biomedical Engineering. Recurrent topics in Seung Mo Jin's work include Immunotherapy and Immune Responses (4 papers), Immune cells in cancer (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Seung Mo Jin is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Immune cells in cancer (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Seung Mo Jin collaborates with scholars based in South Korea, United Kingdom and Sweden. Seung Mo Jin's co-authors include Yong Taik Lim, Hong Sik Shin, Sang Nam Lee, Sohyun Kim, Young Seob Kim, Il-Woo Shin, Yeong‐Min Park, Tae Heung Kang, Young‐Woock Noh and Jung‐Eun Kim and has published in prestigious journals such as Advanced Materials, Nature Communications and Accounts of Chemical Research.

In The Last Decade

Seung Mo Jin

11 papers receiving 433 citations

Peers

Seung Mo Jin

IMMUN

ONCOL

BIOMA

Hong Sik Shin South Korea

Chanyoung Song South Korea

Bolei Dai China

Samuel S.K. Lam United States

Lujia Huang China

Guofeng Ji China

Louis T. Curtis United States

Jiaqi Qin China

Catherine Bessell United States

Nasim Kheshtchin Iran

Hong Sik Shin South Korea

Seung Mo Jin

289 ×1.0

IMMUN

231 ×1.0

119 ×1.0

113 ×1.0

ONCOL

79 ×1.0

BIOMA

Citations per year, relative to Seung Mo Jin Seung Mo Jin (= 1×) peers Hong Sik Shin

Countries citing papers authored by Seung Mo Jin

Since Specialization

Citations

This map shows the geographic impact of Seung Mo Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seung Mo Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seung Mo Jin more than expected).

Fields of papers citing papers by Seung Mo Jin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seung Mo Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seung Mo Jin. The network helps show where Seung Mo Jin may publish in the future.

Co-authorship network of co-authors of Seung Mo Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Seung Mo Jin. A scholar is included among the top collaborators of Seung Mo Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seung Mo Jin. Seung Mo Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Jin, Seung Mo, Jin‐Ho Choi, Hong Sik Shin, et al.. (2024). Transformable Gel‐to‐Nanovaccine Enhances Cancer Immunotherapy via Metronomic‐Like Immunomodulation and Collagen‐Mediated Paracortex Delivery. Advanced Materials. 36(48). e2409914–e2409914. 6 indexed citations

Kwon, Kee Woong, et al.. (2023). Protective Efficacy and Immunogenicity of Rv0351/Rv3628 Subunit Vaccine Formulated in Different Adjuvants Against Mycobacterium tuberculosis Infection. Immune Network. 23(2). e16–e16. 4 indexed citations

Jin, Seung Mo, Hong Sik Shin, Sohyun Kim, et al.. (2023). A nanoadjuvant that dynamically coordinates innate immune stimuli activation enhances cancer immunotherapy and reduces immune cell exhaustion. Nature Nanotechnology. 18(4). 390–402. 88 indexed citations

Shin, Hong Sik, et al.. (2023). Molecular Masking of Synthetic Immunomodulator Evokes Antitumor Immunity With Reduced Immune Tolerance and Systemic Toxicity by Temporal Activity Recovery and Sustained Stimulation. Advanced Materials. 36(9). e2309039–e2309039. 6 indexed citations

Lee, Hyun‐Jong, Seung Mo Jin, Hogene Kim, et al.. (2023). Development and Validation of an Artificial Intelligence-Based Motion Analysis System for Upper Extremity Rehabilitation Exercises in Patients with Spinal Cord Injury: A Randomized Controlled Trial. Healthcare. 12(1). 7–7. 8 indexed citations

Jin, Seung Mo, Sang Nam Lee, Jung Eun Kim, et al.. (2021). Overcoming Chemoimmunotherapy‐Induced Immunosuppression by Assemblable and Depot Forming Immune Modulating Nanosuspension. Advanced Science. 8(19). e2102043–e2102043. 41 indexed citations

Jin, Seung Mo, et al.. (2021). Molecular and Macroscopic Therapeutic Systems for Cytokine‐Based Cancer Immunotherapy. Advanced Therapeutics. 4(8). 1 indexed citations

Karlsson‐Parra, Alex, et al.. (2020). 569P Intratumoral injection of allogeneic pro-inflammatory dendritic cells (ilixadencel) in combination with anti-CTLA-4 treatment induce complete tumour responses and anti-tumour immune memory in a mouse tumour model. Annals of Oncology. 31. S487–S487. 1 indexed citations

Lee, Sang Nam, Seung Mo Jin, Hong Sik Shin, & Yong Taik Lim. (2020). Chemical Strategies to Enhance the Therapeutic Efficacy of Toll-like Receptor Agonist Based Cancer Immunotherapy. Accounts of Chemical Research. 53(10). 2081–2093. 37 indexed citations

10.

Song, Chanyoung, Hathaichanok Phuengkham, Young Seob Kim, et al.. (2019). Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence. Nature Communications. 10(1). 3745–3745. 135 indexed citations

11.

Kim, Sunyoung, Sohyun Kim, Jung‐Eun Kim, et al.. (2019). Lyophilizable and Multifaceted Toll-like Receptor 7/8 Agonist-Loaded Nanoemulsion for the Reprogramming of Tumor Microenvironments and Enhanced Cancer Immunotherapy. ACS Nano. 13(11). 12671–12686. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact